nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C9—brain cancer	0.615	1	CbGaD
Loratadine—CYP2D6—Lomustine—brain cancer	0.0727	0.254	CbGbCtD
Loratadine—CYP2D6—Hydroxyurea—brain cancer	0.0551	0.193	CbGbCtD
Loratadine—CYP3A4—Temozolomide—brain cancer	0.0544	0.19	CbGbCtD
Loratadine—CYP3A4—Lomustine—brain cancer	0.0462	0.162	CbGbCtD
Loratadine—CYP2C8—Etoposide—brain cancer	0.0275	0.0964	CbGbCtD
Loratadine—ABCB1—Etoposide—brain cancer	0.0186	0.0652	CbGbCtD
Loratadine—CYP3A4—Etoposide—brain cancer	0.0112	0.0391	CbGbCtD
Loratadine—Desloratadine—CYP2C9—brain cancer	0.00275	1	CrCbGaD
Loratadine—Lethargy—Lomustine—brain cancer	0.00178	0.0246	CcSEcCtD
Loratadine—Blister—Hydroxyurea—brain cancer	0.00164	0.0226	CcSEcCtD
Loratadine—KCNH2—Hematopoietic Stem Cell Differentiation—FLI1—brain cancer	0.00157	0.066	CbGpPWpGaD
Loratadine—Nightmare—Procarbazine—brain cancer	0.00147	0.0203	CcSEcCtD
Loratadine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00142	0.0598	CbGpPWpGaD
Loratadine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00128	0.0537	CbGpPWpGaD
Loratadine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00116	0.0489	CbGpPWpGaD
Loratadine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00114	0.048	CbGpPWpGaD
Loratadine—Lethargy—Procarbazine—brain cancer	0.00113	0.0156	CcSEcCtD
Loratadine—Alopecia—Lomustine—brain cancer	0.00107	0.0147	CcSEcCtD
Loratadine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00104	0.0437	CbGpPWpGaD
Loratadine—Drug interaction—Carmustine—brain cancer	0.00103	0.0142	CcSEcCtD
Loratadine—Viral infection—Temozolomide—brain cancer	0.00102	0.0141	CcSEcCtD
Loratadine—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00099	0.0417	CbGpPWpGaD
Loratadine—Dermatitis bullous—Hydroxyurea—brain cancer	0.000897	0.0124	CcSEcCtD
Loratadine—Pollakiuria—Procarbazine—brain cancer	0.000885	0.0122	CcSEcCtD
Loratadine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000884	0.0372	CbGpPWpGaD
Loratadine—Drowsiness—Procarbazine—brain cancer	0.000854	0.0118	CcSEcCtD
Loratadine—Cardiovascular disorder—Etoposide—brain cancer	0.00084	0.0116	CcSEcCtD
Loratadine—Pain—Carboplatin—brain cancer	0.000838	0.0116	CcSEcCtD
Loratadine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000813	0.0342	CbGpPWpGaD
Loratadine—Epistaxis—Procarbazine—brain cancer	0.000805	0.0111	CcSEcCtD
Loratadine—Body temperature increased—Carboplatin—brain cancer	0.000775	0.0107	CcSEcCtD
Loratadine—Arrhythmia—Procarbazine—brain cancer	0.000685	0.00944	CcSEcCtD
Loratadine—Body temperature increased—Lomustine—brain cancer	0.000678	0.00935	CcSEcCtD
Loratadine—Alopecia—Procarbazine—brain cancer	0.000677	0.00934	CcSEcCtD
Loratadine—Drowsiness—Hydroxyurea—brain cancer	0.000661	0.00911	CcSEcCtD
Loratadine—Tension—Procarbazine—brain cancer	0.000655	0.00903	CcSEcCtD
Loratadine—Nervousness—Procarbazine—brain cancer	0.000648	0.00894	CcSEcCtD
Loratadine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000625	0.00862	CcSEcCtD
Loratadine—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000614	0.0258	CbGpPWpGaD
Loratadine—Syncope—Procarbazine—brain cancer	0.000598	0.00825	CcSEcCtD
Loratadine—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00059	0.0248	CbGpPWpGaD
Loratadine—Loss of consciousness—Procarbazine—brain cancer	0.000586	0.00809	CcSEcCtD
Loratadine—Cough—Procarbazine—brain cancer	0.000582	0.00803	CcSEcCtD
Loratadine—Hypertension—Procarbazine—brain cancer	0.000576	0.00794	CcSEcCtD
Loratadine—Myalgia—Procarbazine—brain cancer	0.000568	0.00783	CcSEcCtD
Loratadine—Dry mouth—Procarbazine—brain cancer	0.000556	0.00766	CcSEcCtD
Loratadine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000548	0.023	CbGpPWpGaD
Loratadine—Vomiting—Lomustine—brain cancer	0.000545	0.00752	CcSEcCtD
Loratadine—Shock—Procarbazine—brain cancer	0.000536	0.00739	CcSEcCtD
Loratadine—Pollakiuria—Temozolomide—brain cancer	0.000535	0.00738	CcSEcCtD
Loratadine—Depression—Carmustine—brain cancer	0.000533	0.00735	CcSEcCtD
Loratadine—Tachycardia—Procarbazine—brain cancer	0.000532	0.00733	CcSEcCtD
Loratadine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000527	0.0222	CbGpPWpGaD
Loratadine—Alopecia—Hydroxyurea—brain cancer	0.000524	0.00723	CcSEcCtD
Loratadine—Depression—Temozolomide—brain cancer	0.000515	0.0071	CcSEcCtD
Loratadine—Nausea—Lomustine—brain cancer	0.00051	0.00703	CcSEcCtD
Loratadine—Hypotension—Procarbazine—brain cancer	0.000509	0.00702	CcSEcCtD
Loratadine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000504	0.0212	CbGpPWpGaD
Loratadine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000496	0.00684	CcSEcCtD
Loratadine—Insomnia—Procarbazine—brain cancer	0.000493	0.00679	CcSEcCtD
Loratadine—Paraesthesia—Procarbazine—brain cancer	0.000489	0.00674	CcSEcCtD
Loratadine—Hepatobiliary disease—Temozolomide—brain cancer	0.000488	0.00673	CcSEcCtD
Loratadine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000485	0.0204	CbGpPWpGaD
Loratadine—Somnolence—Procarbazine—brain cancer	0.000484	0.00668	CcSEcCtD
Loratadine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000479	0.00661	CcSEcCtD
Loratadine—Fatigue—Procarbazine—brain cancer	0.00047	0.00648	CcSEcCtD
Loratadine—Malaise—Hydroxyurea—brain cancer	0.000466	0.00642	CcSEcCtD
Loratadine—Constipation—Procarbazine—brain cancer	0.000466	0.00642	CcSEcCtD
Loratadine—Pain—Procarbazine—brain cancer	0.000466	0.00642	CcSEcCtD
Loratadine—Pharyngitis—Temozolomide—brain cancer	0.00046	0.00634	CcSEcCtD
Loratadine—Feeling abnormal—Procarbazine—brain cancer	0.000449	0.00619	CcSEcCtD
Loratadine—Gastrointestinal pain—Procarbazine—brain cancer	0.000445	0.00614	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000437	0.00602	CcSEcCtD
Loratadine—Discomfort—Hydroxyurea—brain cancer	0.000434	0.00599	CcSEcCtD
Loratadine—Tinnitus—Temozolomide—brain cancer	0.000432	0.00596	CcSEcCtD
Loratadine—Abdominal pain—Procarbazine—brain cancer	0.000431	0.00594	CcSEcCtD
Loratadine—Body temperature increased—Procarbazine—brain cancer	0.000431	0.00594	CcSEcCtD
Loratadine—Arrhythmia—Carmustine—brain cancer	0.000428	0.00591	CcSEcCtD
Loratadine—Alopecia—Carmustine—brain cancer	0.000424	0.00584	CcSEcCtD
Loratadine—Immune system disorder—Temozolomide—brain cancer	0.000419	0.00577	CcSEcCtD
Loratadine—Nervous system disorder—Hydroxyurea—brain cancer	0.000413	0.0057	CcSEcCtD
Loratadine—Alopecia—Temozolomide—brain cancer	0.00041	0.00565	CcSEcCtD
Loratadine—Skin disorder—Hydroxyurea—brain cancer	0.000409	0.00565	CcSEcCtD
Loratadine—Dysgeusia—Temozolomide—brain cancer	0.000395	0.00545	CcSEcCtD
Loratadine—Asthenia—Procarbazine—brain cancer	0.000391	0.00539	CcSEcCtD
Loratadine—Hepatobiliary disease—Etoposide—brain cancer	0.000391	0.00539	CcSEcCtD
Loratadine—Agitation—Carmustine—brain cancer	0.000384	0.00529	CcSEcCtD
Loratadine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000376	0.0158	CbGpPWpGaD
Loratadine—KCNH2—Hematopoietic Stem Cell Differentiation—VAV1—brain cancer	0.000376	0.0158	CbGpPWpGaD
Loratadine—Somnolence—Hydroxyurea—brain cancer	0.000375	0.00517	CcSEcCtD
Loratadine—Ill-defined disorder—Temozolomide—brain cancer	0.000374	0.00516	CcSEcCtD
Loratadine—Diarrhoea—Procarbazine—brain cancer	0.000373	0.00514	CcSEcCtD
Loratadine—Dyspepsia—Hydroxyurea—brain cancer	0.000371	0.00512	CcSEcCtD
Loratadine—Agitation—Temozolomide—brain cancer	0.000371	0.00511	CcSEcCtD
Loratadine—Angioedema—Temozolomide—brain cancer	0.000369	0.00508	CcSEcCtD
Loratadine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000367	0.0154	CbGpPWpGaD
Loratadine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000364	0.00502	CcSEcCtD
Loratadine—Malaise—Temozolomide—brain cancer	0.000364	0.00502	CcSEcCtD
Loratadine—Fatigue—Hydroxyurea—brain cancer	0.000363	0.00501	CcSEcCtD
Loratadine—Hypertension—Carmustine—brain cancer	0.00036	0.00497	CcSEcCtD
Loratadine—Pain—Hydroxyurea—brain cancer	0.00036	0.00497	CcSEcCtD
Loratadine—Constipation—Hydroxyurea—brain cancer	0.00036	0.00497	CcSEcCtD
Loratadine—Dizziness—Procarbazine—brain cancer	0.00036	0.00497	CcSEcCtD
Loratadine—Palpitations—Temozolomide—brain cancer	0.000357	0.00492	CcSEcCtD
Loratadine—Myalgia—Carmustine—brain cancer	0.000355	0.0049	CcSEcCtD
Loratadine—Chest pain—Carmustine—brain cancer	0.000355	0.0049	CcSEcCtD
Loratadine—Cough—Temozolomide—brain cancer	0.000352	0.00486	CcSEcCtD
Loratadine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00035	0.0147	CbGpPWpGaD
Loratadine—Hypertension—Temozolomide—brain cancer	0.000348	0.0048	CcSEcCtD
Loratadine—Feeling abnormal—Hydroxyurea—brain cancer	0.000347	0.00479	CcSEcCtD
Loratadine—Vomiting—Procarbazine—brain cancer	0.000346	0.00478	CcSEcCtD
Loratadine—Myalgia—Temozolomide—brain cancer	0.000343	0.00474	CcSEcCtD
Loratadine—Rash—Procarbazine—brain cancer	0.000343	0.00474	CcSEcCtD
Loratadine—Dermatitis—Procarbazine—brain cancer	0.000343	0.00473	CcSEcCtD
Loratadine—Headache—Procarbazine—brain cancer	0.000341	0.0047	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000341	0.0047	CcSEcCtD
Loratadine—Discomfort—Temozolomide—brain cancer	0.000339	0.00468	CcSEcCtD
Loratadine—Dry mouth—Temozolomide—brain cancer	0.000336	0.00463	CcSEcCtD
Loratadine—Immune system disorder—Etoposide—brain cancer	0.000335	0.00462	CcSEcCtD
Loratadine—Body temperature increased—Hydroxyurea—brain cancer	0.000333	0.00459	CcSEcCtD
Loratadine—Tachycardia—Carmustine—brain cancer	0.000333	0.00459	CcSEcCtD
Loratadine—KCNH2—SIDS Susceptibility Pathways—HES5—brain cancer	0.00033	0.0139	CbGpPWpGaD
Loratadine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000329	0.0139	CbGpPWpGaD
Loratadine—Anaphylactic shock—Temozolomide—brain cancer	0.000329	0.00454	CcSEcCtD
Loratadine—Alopecia—Etoposide—brain cancer	0.000328	0.00452	CcSEcCtD
Loratadine—Nausea—Procarbazine—brain cancer	0.000323	0.00446	CcSEcCtD
Loratadine—Nervous system disorder—Temozolomide—brain cancer	0.000323	0.00445	CcSEcCtD
Loratadine—Skin disorder—Temozolomide—brain cancer	0.00032	0.00441	CcSEcCtD
Loratadine—Hypotension—Carmustine—brain cancer	0.000318	0.00439	CcSEcCtD
Loratadine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000317	0.0133	CbGpPWpGaD
Loratadine—Dysgeusia—Etoposide—brain cancer	0.000316	0.00436	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00031	0.00428	CcSEcCtD
Loratadine—Insomnia—Carmustine—brain cancer	0.000308	0.00425	CcSEcCtD
Loratadine—Paraesthesia—Carmustine—brain cancer	0.000306	0.00422	CcSEcCtD
Loratadine—Somnolence—Carmustine—brain cancer	0.000303	0.00418	CcSEcCtD
Loratadine—Asthenia—Hydroxyurea—brain cancer	0.000302	0.00417	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.0003	0.00414	CcSEcCtD
Loratadine—Ill-defined disorder—Etoposide—brain cancer	0.0003	0.00413	CcSEcCtD
Loratadine—Insomnia—Temozolomide—brain cancer	0.000298	0.00411	CcSEcCtD
Loratadine—Paraesthesia—Temozolomide—brain cancer	0.000296	0.00408	CcSEcCtD
Loratadine—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000295	0.0124	CbGpPWpGaD
Loratadine—Gastrointestinal disorder—Carmustine—brain cancer	0.000294	0.00406	CcSEcCtD
Loratadine—Somnolence—Temozolomide—brain cancer	0.000293	0.00404	CcSEcCtD
Loratadine—Pain—Carmustine—brain cancer	0.000291	0.00402	CcSEcCtD
Loratadine—Constipation—Carmustine—brain cancer	0.000291	0.00402	CcSEcCtD
Loratadine—Malaise—Etoposide—brain cancer	0.000291	0.00401	CcSEcCtD
Loratadine—Dyspepsia—Temozolomide—brain cancer	0.00029	0.004	CcSEcCtD
Loratadine—Diarrhoea—Hydroxyurea—brain cancer	0.000288	0.00398	CcSEcCtD
Loratadine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000284	0.00392	CcSEcCtD
Loratadine—Fatigue—Temozolomide—brain cancer	0.000284	0.00391	CcSEcCtD
Loratadine—Loss of consciousness—Etoposide—brain cancer	0.000284	0.00391	CcSEcCtD
Loratadine—Cough—Etoposide—brain cancer	0.000282	0.00389	CcSEcCtD
Loratadine—Constipation—Temozolomide—brain cancer	0.000282	0.00388	CcSEcCtD
Loratadine—Pain—Temozolomide—brain cancer	0.000282	0.00388	CcSEcCtD
Loratadine—Feeling abnormal—Carmustine—brain cancer	0.000281	0.00387	CcSEcCtD
Loratadine—Hypertension—Etoposide—brain cancer	0.000279	0.00384	CcSEcCtD
Loratadine—Dizziness—Hydroxyurea—brain cancer	0.000279	0.00384	CcSEcCtD
Loratadine—Gastrointestinal pain—Carmustine—brain cancer	0.000279	0.00384	CcSEcCtD
Loratadine—Chest pain—Etoposide—brain cancer	0.000275	0.00379	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000273	0.00376	CcSEcCtD
Loratadine—Discomfort—Etoposide—brain cancer	0.000272	0.00374	CcSEcCtD
Loratadine—Feeling abnormal—Temozolomide—brain cancer	0.000271	0.00374	CcSEcCtD
Loratadine—Abdominal pain—Carmustine—brain cancer	0.000269	0.00371	CcSEcCtD
Loratadine—Body temperature increased—Carmustine—brain cancer	0.000269	0.00371	CcSEcCtD
Loratadine—Gastrointestinal pain—Temozolomide—brain cancer	0.000269	0.00371	CcSEcCtD
Loratadine—Vomiting—Hydroxyurea—brain cancer	0.000268	0.0037	CcSEcCtD
Loratadine—Rash—Hydroxyurea—brain cancer	0.000266	0.00366	CcSEcCtD
Loratadine—Dermatitis—Hydroxyurea—brain cancer	0.000265	0.00366	CcSEcCtD
Loratadine—Headache—Hydroxyurea—brain cancer	0.000264	0.00364	CcSEcCtD
Loratadine—Anaphylactic shock—Etoposide—brain cancer	0.000263	0.00363	CcSEcCtD
Loratadine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000263	0.0111	CbGpPWpGaD
Loratadine—Abdominal pain—Temozolomide—brain cancer	0.00026	0.00359	CcSEcCtD
Loratadine—Body temperature increased—Temozolomide—brain cancer	0.00026	0.00359	CcSEcCtD
Loratadine—Tachycardia—Etoposide—brain cancer	0.000257	0.00355	CcSEcCtD
Loratadine—Skin disorder—Etoposide—brain cancer	0.000256	0.00353	CcSEcCtD
Loratadine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000255	0.0107	CbGpPWpGaD
Loratadine—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000252	0.0106	CbGpPWpGaD
Loratadine—Nausea—Hydroxyurea—brain cancer	0.00025	0.00345	CcSEcCtD
Loratadine—Hypotension—Etoposide—brain cancer	0.000246	0.0034	CcSEcCtD
Loratadine—Asthenia—Carmustine—brain cancer	0.000244	0.00337	CcSEcCtD
Loratadine—Paraesthesia—Etoposide—brain cancer	0.000237	0.00326	CcSEcCtD
Loratadine—Asthenia—Temozolomide—brain cancer	0.000236	0.00326	CcSEcCtD
Loratadine—Somnolence—Etoposide—brain cancer	0.000234	0.00323	CcSEcCtD
Loratadine—Diarrhoea—Carmustine—brain cancer	0.000233	0.00321	CcSEcCtD
Loratadine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000228	0.00957	CbGpPWpGaD
Loratadine—Gastrointestinal disorder—Etoposide—brain cancer	0.000227	0.00314	CcSEcCtD
Loratadine—Fatigue—Etoposide—brain cancer	0.000227	0.00313	CcSEcCtD
Loratadine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000226	0.00951	CbGpPWpGaD
Loratadine—Dizziness—Carmustine—brain cancer	0.000225	0.00311	CcSEcCtD
Loratadine—Constipation—Etoposide—brain cancer	0.000225	0.00311	CcSEcCtD
Loratadine—Pain—Etoposide—brain cancer	0.000225	0.00311	CcSEcCtD
Loratadine—Diarrhoea—Temozolomide—brain cancer	0.000225	0.00311	CcSEcCtD
Loratadine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000225	0.00944	CbGpPWpGaD
Loratadine—Dizziness—Temozolomide—brain cancer	0.000218	0.003	CcSEcCtD
Loratadine—Feeling abnormal—Etoposide—brain cancer	0.000217	0.00299	CcSEcCtD
Loratadine—Vomiting—Carmustine—brain cancer	0.000217	0.00299	CcSEcCtD
Loratadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000216	0.00906	CbGpPWpGaD
Loratadine—Gastrointestinal pain—Etoposide—brain cancer	0.000215	0.00297	CcSEcCtD
Loratadine—Rash—Carmustine—brain cancer	0.000215	0.00296	CcSEcCtD
Loratadine—Dermatitis—Carmustine—brain cancer	0.000215	0.00296	CcSEcCtD
Loratadine—Headache—Carmustine—brain cancer	0.000213	0.00294	CcSEcCtD
Loratadine—Vomiting—Temozolomide—brain cancer	0.000209	0.00289	CcSEcCtD
Loratadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000209	0.0088	CbGpPWpGaD
Loratadine—Body temperature increased—Etoposide—brain cancer	0.000208	0.00287	CcSEcCtD
Loratadine—Abdominal pain—Etoposide—brain cancer	0.000208	0.00287	CcSEcCtD
Loratadine—Rash—Temozolomide—brain cancer	0.000208	0.00286	CcSEcCtD
Loratadine—Dermatitis—Temozolomide—brain cancer	0.000207	0.00286	CcSEcCtD
Loratadine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000207	0.00869	CbGpPWpGaD
Loratadine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000207	0.00869	CbGpPWpGaD
Loratadine—Headache—Temozolomide—brain cancer	0.000206	0.00284	CcSEcCtD
Loratadine—Nausea—Carmustine—brain cancer	0.000202	0.00279	CcSEcCtD
Loratadine—Nausea—Temozolomide—brain cancer	0.000196	0.0027	CcSEcCtD
Loratadine—Asthenia—Etoposide—brain cancer	0.000189	0.00261	CcSEcCtD
Loratadine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000184	0.00776	CbGpPWpGaD
Loratadine—Diarrhoea—Etoposide—brain cancer	0.00018	0.00249	CcSEcCtD
Loratadine—Dizziness—Etoposide—brain cancer	0.000174	0.0024	CcSEcCtD
Loratadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00017	0.00713	CbGpPWpGaD
Loratadine—Vomiting—Etoposide—brain cancer	0.000168	0.00231	CcSEcCtD
Loratadine—Rash—Etoposide—brain cancer	0.000166	0.00229	CcSEcCtD
Loratadine—Dermatitis—Etoposide—brain cancer	0.000166	0.00229	CcSEcCtD
Loratadine—Headache—Etoposide—brain cancer	0.000165	0.00228	CcSEcCtD
Loratadine—Nausea—Etoposide—brain cancer	0.000156	0.00216	CcSEcCtD
Loratadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000143	0.00602	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00014	0.0059	CbGpPWpGaD
Loratadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000137	0.00575	CbGpPWpGaD
Loratadine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000135	0.00568	CbGpPWpGaD
Loratadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000128	0.00536	CbGpPWpGaD
Loratadine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000116	0.00489	CbGpPWpGaD
Loratadine—HRH1—IL-4 Signaling Pathway—IRS2—brain cancer	0.000115	0.00484	CbGpPWpGaD
Loratadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000111	0.00466	CbGpPWpGaD
Loratadine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.00011	0.00462	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—HES1—brain cancer	0.000109	0.00458	CbGpPWpGaD
Loratadine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000108	0.00455	CbGpPWpGaD
Loratadine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000103	0.00433	CbGpPWpGaD
Loratadine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	9.8e-05	0.00412	CbGpPWpGaD
Loratadine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	9.66e-05	0.00406	CbGpPWpGaD
Loratadine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	9.01e-05	0.00379	CbGpPWpGaD
Loratadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	8.93e-05	0.00376	CbGpPWpGaD
Loratadine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	8.89e-05	0.00374	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—PTCH2—brain cancer	8.03e-05	0.00338	CbGpPWpGaD
Loratadine—HRH1—IL-4 Signaling Pathway—RELA—brain cancer	7.94e-05	0.00334	CbGpPWpGaD
Loratadine—HRH1—G alpha (q) signalling events—TRPC6—brain cancer	7.91e-05	0.00333	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	7.07e-05	0.00297	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—OR4C12—brain cancer	7.04e-05	0.00296	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—OR14C36—brain cancer	7.04e-05	0.00296	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—OR4C12—brain cancer	6.39e-05	0.00269	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—OR14C36—brain cancer	6.39e-05	0.00269	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	6.09e-05	0.00256	CbGpPWpGaD
Loratadine—HRH1—IL-4 Signaling Pathway—STAT3—brain cancer	6.02e-05	0.00253	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.89e-05	0.00248	CbGpPWpGaD
Loratadine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.81e-05	0.00244	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.46e-05	0.0023	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.08e-05	0.00214	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	4.82e-05	0.00203	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—VEGFA—brain cancer	4.81e-05	0.00202	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.22e-05	0.00177	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.21e-05	0.00177	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—SHH—brain cancer	4.14e-05	0.00174	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PTCH2—brain cancer	4.12e-05	0.00173	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.07e-05	0.00171	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—PTCH1—brain cancer	3.92e-05	0.00165	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—SMO—brain cancer	3.92e-05	0.00165	CbGpPWpGaD
Loratadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.81e-05	0.0016	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—OR4C12—brain cancer	3.78e-05	0.00159	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—OR14C36—brain cancer	3.78e-05	0.00159	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.76e-05	0.00158	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—ABR—brain cancer	3.56e-05	0.0015	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.34e-05	0.0014	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—IL2—brain cancer	3.32e-05	0.0014	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.28e-05	0.00138	CbGpPWpGaD
Loratadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.26e-05	0.00137	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.23e-05	0.00136	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—ABR—brain cancer	3.23e-05	0.00136	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—DTX2—brain cancer	3.21e-05	0.00135	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.08e-05	0.0013	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.01e-05	0.00126	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.87e-05	0.00121	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.83e-05	0.00119	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.75e-05	0.00116	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.51e-05	0.00105	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.48e-05	0.00104	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTCH2—brain cancer	2.43e-05	0.00102	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HES5—brain cancer	2.36e-05	0.000991	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.33e-05	0.000981	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STRADA—brain cancer	2.29e-05	0.000962	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—TRPC6—brain cancer	2.25e-05	0.000948	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—SHH—brain cancer	2.12e-05	0.000893	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—TRPC6—brain cancer	2.05e-05	0.000861	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—SMO—brain cancer	2.01e-05	0.000846	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PTCH1—brain cancer	2.01e-05	0.000846	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.95e-05	0.000818	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ABR—brain cancer	1.91e-05	0.000803	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP2C9—brain cancer	1.88e-05	0.000789	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GLI2—brain cancer	1.84e-05	0.000776	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.81e-05	0.000761	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.81e-05	0.000761	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GLI1—brain cancer	1.73e-05	0.000729	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—VAV1—brain cancer	1.69e-05	0.00071	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2C9—brain cancer	1.68e-05	0.000705	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SUFU—brain cancer	1.64e-05	0.000691	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2C9—brain cancer	1.64e-05	0.000688	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.6e-05	0.000673	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—BSG—brain cancer	1.6e-05	0.000671	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GFAP—brain cancer	1.59e-05	0.000667	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.58e-05	0.000666	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.54e-05	0.000648	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—VAV1—brain cancer	1.53e-05	0.000645	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HEY1—brain cancer	1.5e-05	0.000632	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—DLL1—brain cancer	1.47e-05	0.00062	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—BSG—brain cancer	1.42e-05	0.000599	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.39e-05	0.000586	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—BSG—brain cancer	1.39e-05	0.000585	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—IDH1—brain cancer	1.37e-05	0.000577	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—BSG—brain cancer	1.31e-05	0.000551	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—BSG—brain cancer	1.3e-05	0.000546	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.28e-05	0.00054	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.25e-05	0.000528	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SHH—brain cancer	1.25e-05	0.000527	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—IDH1—brain cancer	1.23e-05	0.000515	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TRPC6—brain cancer	1.21e-05	0.000508	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—IDH1—brain cancer	1.2e-05	0.000503	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTCH1—brain cancer	1.19e-05	0.0005	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SMO—brain cancer	1.19e-05	0.0005	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—IDH1—brain cancer	1.13e-05	0.000474	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.12e-05	0.00047	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—IDH1—brain cancer	1.12e-05	0.00047	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ENO2—brain cancer	1.08e-05	0.000456	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.07e-05	0.000451	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.05e-05	0.000443	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.01e-05	0.000424	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.98e-06	0.00042	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	9.74e-06	0.000409	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ENO2—brain cancer	9.68e-06	0.000407	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOTCH2—brain cancer	9.5e-06	0.0004	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ENO2—brain cancer	9.45e-06	0.000398	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.1e-06	0.000383	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VAV1—brain cancer	9.06e-06	0.000381	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ENO2—brain cancer	8.91e-06	0.000375	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ENO2—brain cancer	8.83e-06	0.000371	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—BSG—brain cancer	8.57e-06	0.00036	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HES1—brain cancer	7.79e-06	0.000328	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—IL2—brain cancer	7.54e-06	0.000317	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDGFRA—brain cancer	7.42e-06	0.000312	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—IDH1—brain cancer	7.37e-06	0.00031	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SPP1—brain cancer	7.2e-06	0.000303	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL2—brain cancer	6.85e-06	0.000288	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IRS2—brain cancer	6.51e-06	0.000274	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ENO2—brain cancer	5.82e-06	0.000245	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APC—brain cancer	5.75e-06	0.000242	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CG—brain cancer	5.75e-06	0.000242	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—EGFR—brain cancer	5.24e-06	0.00022	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CG—brain cancer	4.98e-06	0.000209	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RELA—brain cancer	4.49e-06	0.000189	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB2—brain cancer	4.47e-06	0.000188	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CG—brain cancer	4.44e-06	0.000187	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CG—brain cancer	4.34e-06	0.000182	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.09e-06	0.000172	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.05e-06	0.00017	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2—brain cancer	4.05e-06	0.00017	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCND1—brain cancer	3.95e-06	0.000166	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CTNNB1—brain cancer	3.91e-06	0.000164	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—brain cancer	3.44e-06	0.000145	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STAT3—brain cancer	3.41e-06	0.000143	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MYC—brain cancer	3.16e-06	0.000133	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGFR—brain cancer	3.1e-06	0.00013	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.67e-06	0.000112	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—brain cancer	2.6e-06	0.000109	CbGpPWpGaD
